Who
Anatol Kreitzer
Chief Discovery Officer
Company insider
Files Form 4 as: Chief Discovery Officer, MapLight Therapeutics.
In numbers
- Trades disclosed
- 35
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $5.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Oct 2025
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $96K12,248 at $7.84 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,020 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,455 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,455 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,020 at $0.00 | filing |
| 17 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $105K2,833 at $37.05 | filing |
| 17 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $533K14,140 at $37.70 | filing |
| 17 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,678200 at $38.39 | filing |
| 17 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $105K2,833 at $37.05 | filing |
| 17 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $533K14,140 at $37.70 | filing |
| 17 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,678200 at $38.39 | filing |
| 16 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $274K7,464 at $36.66 | filing |
| 16 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $60K1,592 at $37.44 | filing |
| 16 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $274K7,464 at $36.66 | filing |
| 16 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $60K1,592 at $37.44 | filing |
| 15 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $200K5,545 at $36.13 | filing |
| 15 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $167K4,510 at $36.94 | filing |
| 15 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $200K5,545 at $36.13 | filing |
| 15 Jul 2026filed 20 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $167K4,510 at $36.94 | filing |
| 27 Apr 2026filed 29 Apr 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $242K8,346 at $28.96 | filing |
News
No headline names them, or the companies they trade most, lately.